Cargando…
Pharmacotherapy for anxiety disorders in children and adolescents
Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263391/ https://www.ncbi.nlm.nih.gov/pubmed/22275849 |
_version_ | 1782221855685345280 |
---|---|
author | Kodish, Ian Rockhill, Carol Varley, Chris |
author_facet | Kodish, Ian Rockhill, Carol Varley, Chris |
author_sort | Kodish, Ian |
collection | PubMed |
description | Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus on the evidence base of pharmacologic treatment and important clinical considerations to optimize care. We then briefly describe the impact of anxiety on neuronal elements of fear circuitry to highlight how treatments may ameliorate impairments through enhanced plasticity Overall, pharmacotherapy for anxiety disorders is effective in improving clinical symptoms, particularly in combination with psychotherapy. Response is typically seen within several weeks, yet longitudinal studies are limited. Selective serotonin reuptake inhibitors are thought to be relatively safe and effective for acute treatment of several classes of anxiety disorders in youth, with increasing evidence supporting the role of neuronal plasticity in recovery. |
format | Online Article Text |
id | pubmed-3263391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-32633912012-01-24 Pharmacotherapy for anxiety disorders in children and adolescents Kodish, Ian Rockhill, Carol Varley, Chris Dialogues Clin Neurosci Pharmacological Aspects Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus on the evidence base of pharmacologic treatment and important clinical considerations to optimize care. We then briefly describe the impact of anxiety on neuronal elements of fear circuitry to highlight how treatments may ameliorate impairments through enhanced plasticity Overall, pharmacotherapy for anxiety disorders is effective in improving clinical symptoms, particularly in combination with psychotherapy. Response is typically seen within several weeks, yet longitudinal studies are limited. Selective serotonin reuptake inhibitors are thought to be relatively safe and effective for acute treatment of several classes of anxiety disorders in youth, with increasing evidence supporting the role of neuronal plasticity in recovery. Les Laboratoires Servier 2011-12 /pmc/articles/PMC3263391/ /pubmed/22275849 Text en Copyright: © 2011 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmacological Aspects Kodish, Ian Rockhill, Carol Varley, Chris Pharmacotherapy for anxiety disorders in children and adolescents |
title | Pharmacotherapy for anxiety disorders in children and adolescents |
title_full | Pharmacotherapy for anxiety disorders in children and adolescents |
title_fullStr | Pharmacotherapy for anxiety disorders in children and adolescents |
title_full_unstemmed | Pharmacotherapy for anxiety disorders in children and adolescents |
title_short | Pharmacotherapy for anxiety disorders in children and adolescents |
title_sort | pharmacotherapy for anxiety disorders in children and adolescents |
topic | Pharmacological Aspects |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263391/ https://www.ncbi.nlm.nih.gov/pubmed/22275849 |
work_keys_str_mv | AT kodishian pharmacotherapyforanxietydisordersinchildrenandadolescents AT rockhillcarol pharmacotherapyforanxietydisordersinchildrenandadolescents AT varleychris pharmacotherapyforanxietydisordersinchildrenandadolescents |